Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 12, 2021
Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma.
Journal: British journal of haematology
Published: February 13, 2020
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.
Journal: Journal of medical economics
Published: October 31, 2018
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Journal: The New England journal of medicine
Published: December 12, 2017
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
Journal: The oncologist
Published: October 17, 2017
Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Journal: Journal of medical economics
Published: August 08, 2017
Real-World Economic Burden Associated with Transplantation-Related Complications.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: March 24, 2017
Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 16, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.
Journal: Leukemia research
Published: October 21, 2015
Last Updated: 09/26/2026